Point72 Hong Kong LTD Nevro Corp Transaction History

Point72 Hong Kong LTD

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$40.85 - $77.67 $95,997 - $182,524	-2,350 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$59.95 - $92.06 $140,882 - $216,341	2,350 New	2,350 $170,000
Q4 2021 Feb 14, 2022	SELL	$81.07 - $121.29 $42,642 - $63,798	-526 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$101.99 - $166.36 $82,815 - $135,084	-812 Reduced 60.69%	526 $61,000
Q2 2021 Aug 16, 2021	BUY	$141.6 - $179.06 $135,511 - $171,360	957 Added 251.18%	1,338 $222,000
Q1 2021 May 17, 2021	BUY	$132.81 - $182.18 $50,600 - $69,410	381 New	381 $53,000
Q3 2020 Nov 16, 2020	SELL	$114.09 - $145.51 $40,616 - $51,801	-356 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$89.45 - $129.85 $31,844 - $46,226	356 New	356 $43,000
Q1 2019 May 15, 2019	SELL	$35.52 - $62.62 $9,448 - $16,656	-266 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$35.43 - $56.29 $2,515 - $3,996	-71 Reduced 21.07%	266 $10,000
Q3 2018 Nov 14, 2018	BUY	$44.22 - $75.47 $14,902 - $25,433	337 New	337 $19,000

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $133M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.